Effectiveness of Rebound Therapy in Parkinson's Patients

Parkinson Disease Clinical Trial

Official title:

Effectiveness of Rebound Therapy on Balance and Gait in Parkinson's Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05855161
• Other study ID #: 5-PD-Rebound therapy-RCT
• Status: Completed
• Phase: N/A
• Start date: April 10, 2023
• Est. completion date: December 10, 2023

Study information

• Verified date: December 2023
• Source: Gazi University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Today, physiotherapy approaches in Parkinson's Disease (PD) form the basis of optimal treatment together with medical and surgical treatment. It is stated that various rehabilitation interventions may be effective in the field of physiotherapy. The frequently preferred among these rehabilitation interventions is the conventional treatment approach. In the conventional treatment, various exercises are preferred to improve balance and walking, as well as stretching and strengthening. On the other hand, rebound therapy require strong integration of the neuromuscular system and provide more active use of lower extremity muscle strength. Rebound therapy have been shown to be effective in improving balance in many neurological disease groups, but there is very little study on rebound therapy in PD. It was shown that rebound therapy improve proprioceptive sense, joint range of motion and quality of life. On the other hand, no study has been found showing its effect on balance and walking. Therefore, there is a need to investigate the effectiveness of rebound therapy on balance and walking.

Description:

This study is a randomized controlled study. The patients will be randomly divided into two groups as rebound and control. The rebound group will perform exercises on a trampoline, consisting of 15 minutes of trunk and extremity stretching, 10 minutes of walking, and approximately 30 minutes of task-oriented exercises, twice a week for six weeks. While the control group will follow the same program as the rebound group, they will only perform task-oriented exercises on a stable surface, unlike the rebound group. As the outcome measures, disease severity and disability, balance, and gait performance will be evaluated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 17
• Est. completion date: December 10, 2023
• Est. primary completion date: November 10, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 80 Years

Eligibility

Inclusion Criteria:

• 40-80 years of age

• Having diagnosed with "Parkinson's Disease" by a specialist physician

• Having between 1-3 stages according to the Hoehn and Yahr Scale

• Mini-Mental Test score more than or equal 24

Exclusion Criteria:

• Any orthopedic, vision, hearing, cardiovascular, or perception problems that may affect the research results

Related Conditions & MeSH terms

• Parkinson Disease

Intervention

Other:
• Rebound therapy
Participants will receive exercise-based training on a trampoline
• Exercises on a stable surface
Participants will receive exercise-based training on a stable surface

Locations

Country	Name	City	State
Turkey	Sivas Cumhuriyet University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation	Sivas

Sponsors (1)

Lead Sponsor	Collaborator
Gazi University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Daneshvar P, Ghasemi G, Zolaktaf V, Karimi MT. Comparison of the Effect of 8-Week Rebound Therapy-Based Exercise Program and Weight-Supported Exercises on the Range of Motion, Proprioception, and the Quality of Life in Patients with Parkinson's Disease. Int J Prev Med. 2019 Aug 12;10:131. doi: 10.4103/ijpvm.IJPVM_527_18. eCollection 2019. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Static Balance- Baseline	Assessment will be made with the Biodex Balance System	Assessment will be conducted before the intervention
Primary	Static Balance- Post intervention	Assessment will be made with the Biodex Balance System	Assessment will be conducted immediately after the intervention
Primary	Gait speed- Baseline	Assessment will be made with the BTS G-Walk, (BTS SpA, Via della Croce Rossa, 11 Padova, Italy; SN: 0213-0378) during gait	Assessment will be conducted before the intervention
Primary	Gait speed- Post intervention	Assessment will be made with the BTS G-Walk, (BTS SpA, Via della Croce Rossa, 11 Padova, Italy; SN: 0213-0378) during gait	Assessment will be conducted immediately after the intervention
Primary	Knee strength- Baseline	Assessment will be made with an isokinetic dynamometer (Cybex Humac Norm Testing and Rehabilitation System, CSMI, USA)	Assessment will be conducted before the intervention
Primary	Knee strength-Post intervention	Assessment will be made with an isokinetic dynamometer (Cybex Humac Norm Testing and Rehabilitation System, CSMI, USA)	Assessment will be conducted immediately after the intervention